China Post-Market Clinical Follow-up of FACILLE®

NCT05294562•SciVision Biotech Inc.

Summary

The results showed that subjects tolerated the Sodium Hyaluronate Gel for Injection (FACILLE®) well, with no systemic AEs, SAEs, and unanticipated AEs and associated with high satisfaction and self-evaluated effectiveness. Nearly half of the subjects maintained correction for 12 months and were satisfied with the product 3 years after the first injection.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 18 years or older of male or female;
•Have used or plan to use FACILLE® Sodium Hyaluronate Gel for Injection;
•Agree to participate and comply with the follow-up schedule of this study.

Exclusion Criteria

•With a history of hypersensitivity or allergy to hyaluronic acid or any component of the device;
•Other circumstances were judged to be unsuitable for participating in the study by the investigator.

Key Dates

Start Date

December 14, 2016

Primary Completion Date

May 7, 2017

Completion Date

May 12, 2020

Last Updated

March 24, 2022

Enrollment

1,552

ACTUAL participants

Conditions

Dermal FillerHyaluronic AcidNasolabial Fold

Evaluation of Facial HA Dermal Fillers in Real-Life Conditions

NCT07255261

Lips EnhancementPerioral Wrinkles+3 more

View study

RECRUITINGNA

Oral Supplementation Compared With Hyaluronic Acid Infiltration in Rotator Cuff Tendinopathies

NCT06379997

Tendinitis of ShoulderHyaluronic Acid+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 24, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

China Post-Market Clinical Follow-up of FACILLE®

Inclusion Criteria

Exclusion Criteria

Evaluation of Facial HA Dermal Fillers in Real-Life Conditions

Oral Supplementation Compared With Hyaluronic Acid Infiltration in Rotator Cuff Tendinopathies

Prospective, Multicentre, Randomized, Blind, Parallel-controlled Clinical Trial Evaluating the Efficacy and Safety of Recombinant Collagen Gel for Correcting Moderate to Severe Nasolabial Wrinkles

Randomized Masked Trial of Injectable Cross-Linked Hyaluronic Acid for Moderate-to-Severe Nasolabial Folds

Post Market Clinical Follow up Evaluating the Performance and Safety of Juläine(TM) on Nasolabial Fold Wrinkles

Safety Study of TPX-121 on Nasolabial Folds